Search results

  1. Rheumatoid arthritis

    Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart

  2. Entrectinib for treating ROS1-positive advanced non-small-cell lung cancer (TA643)

    Evidence-based recommendations on entrectinib (Rozlytrek) for ROS1-positive advanced non-small-cell lung cancer (NSCLC) in adults who have not had ROS1

  3. Entrectinib for treating NTRK fusion-positive solid tumours (TA644)

    Evidence-based recommendations on entrectinib (Rozlytrek) for treating neurotrophic tyrosine receptor kinase (NTRK) fusion-positive solid tumours in adults and

  4. Decision-making and mental capacity

    Everything NICE has said on decision-making for people who may, now or in the future, lack capacity to make their own decision in an interactive flowchart

  5. Hepatitis B (chronic)

    Everything NICE has said on diagnosing and managing chronic hepatitis B in children, young people and adults in an interactive flowchart

  6. Motor neurone disease

    Everything NICE has said on assessing and managing motor neurone disease in adults in an interactive flowchart

  7. Eye conditions

    Everything NICE has said on eye conditions in an interactive flowchart

  8. Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant (TA640)

    Evidence-based recommendations on treosulfan (Trecondi) with fludarabine for conditioning treatment before allogeneic haematopoietic stem cell transplant for

  9. Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease (IPG677)

    Evidence-based recommendations on electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney

  10. Chronic heart failure

    Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart

  11. Myeloma

    Everything NICE has said on diagnosing and managing myeloma, and preventing and managing its complications in an interactive flowchart

  12. Advanced breast cancer

    Everything NICE has said on diagnosing and treating advanced breast cancer in an interactive flowchart

  13. Cirrhosis

    Everything NICE has said on assessing and managing suspected or confirmed cirrhosis in people over 16 in an interactive flowchart

  14. Non-alcoholic fatty liver disease

    Everything NICE has said on diagnosing and managing non-alcoholic fatty liver disease and advanced liver fibrosis in an interactive flowchart

  15. COVID-19 rapid guideline: haematopoietic stem cell transplantation (NG164)

    The purpose of this guideline is to maximise the safety of patients who need haemopoietic stem cell transplantation and make the best use of NHS resources, while protecting staff from infection.

  16. Child abuse and neglect

    Everything NICE has said on child abuse and neglect in an interactive flowchart

  17. COVID-19 rapid guideline: arranging planned care in hospitals and diagnostic services (NG179)

    The purpose of this guideline is to help healthcare professionals deliver efficient planned care while minimising the risk of COVID-19 in the context of increasing or decreasing local prevalence. It also aims to help patients make decisions about their planned care.

  18. Autism spectrum disorder

    Everything NICE has said on recognition, referral, diagnosis and management of autism in an interactive flowchart

  19. Neonatal jaundice

    Everything NICE has said on diagnosing and treating jaundice in newborn babies under 28 days in an interactive flowchart

  20. Pancreatitis

    Everything NICE has said on pancreatitis in an interactive flowchart

  21. Organ donation for transplantation

    Everything NICE has said on improving donor identification and consent rates for deceased organ donation for transplantation in an interactive flowchart

  22. Neonatal parenteral nutrition

    Everything NICE has said on parenteral nutrition (intravenous feeding) for newborn babies in an interactive flowchart.

  23. COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders (NG167)

    The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection. It also enables services to make the best use of NHS resources.

  24. Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer (TA638)

    Evidence-based recommendations on atezolizumab (Tecentriq) for untreated extensive-stage small-cell lung cancer in adults

  25. Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer (TA639)

    Evidence-based recommendations on atezolizumab (Tecentriq) with nab-paclitaxel for triple-negative, unresectable, PD-L1-positive, locally advanced or metastatic